Cyclosporine formulations: is there really a difference?

Author： Masri M.A.   Stephan A.   Barbari A.   Rizk S.   Kelany H.   Kamel G.  

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.32, Iss.7, 2000-11, pp. : 1468-1469

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recommendations concerning the introduction of generic formulations of cyclosporine

By Kahan B.D.  

Transplantation Proceedings, Vol. 31, Iss. 3, 1999-05 ,pp. : 1634-1634

Elsevier

Access to resources Recommend Favorite

Discussion of recommendations concerning the introduction of generic formulations of cyclosporine

By Kahan B.D.  

Transplantation Proceedings, Vol. 31, Iss. 3, 1999-05 ,pp. : 1675-1684

Elsevier

Access to resources Recommend Favorite

Donor compensation and remuneration – is there really a difference?

By  

ISBT SCIENCE SERIES, Vol. 11, Iss. S1, 2016-01 ,pp. : 3-9

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-term safety studies: insights into requirements for changing cyclosporine formulations

By Lodge J.P.A.  

Transplantation Proceedings, Vol. 31, Iss. 3, 1999-05 ,pp. : 1664-1666

Elsevier

Access to resources Recommend Favorite

Experience With New Cyclosporine Formulations: Consupren and Neoral in Renal Transplant Patients

By Barbari A.   Stephan A.   Kamel G.   Kilany H.   Masri M.A.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 2941-2944

Elsevier

Access to resources Recommend Favorite